CD8A and neoplasm: Given the importance of Drp1 in regulating multiple processes in T cells, we asked whether the ability of anti‐PD‐1 therapy to reduce solid tumor growth requires the restoration of Drp1 activity in tumor‐infiltrating PD‐1pos CD8+ T cells.